Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Fraldi

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The EMBO Journal|June 18, 2004
Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitorAnnemieke A Michels, Alessandro Fraldi, Qintong Li, et al.
Annals of the Rheumatic Diseases|November 3, 2012
Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)Tiziana Bachetti, Sabrina Chiesa, Patrizio Castagnola, et al.
Developmental Cell|September 6, 2011
Transcriptional activation of lysosomal exocytosis promotes cellular clearanceDiego L Medina, Alessandro Fraldi, Valentina Bouche, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2022
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage DiseaseAntonio Monaco, Veronica Maffia, Nicolina Cristina Sorrentino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 23, 2020
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage DiseaseAntonio Monaco, Veronica Maffia, Nicolina Cristina Sorrentino, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIANicolina Cristina Sorrentino, Vincenzo Cacace, Maria De Risi, et al.
Human Gene Therapy|February 15, 2014
Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I/II trialMarc Tardieu, Michel Zérah, Béatrice Husson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 8, 2015
A Comprehensive Map of CNS Transduction by Eight Recombinant Adeno-associated Virus Serotypes Upon Cerebrospinal Fluid Administration in PigsNicolina Cristina Sorrentino, Veronica Maffia, Sandra Strollo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2024
Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIAMarianna Giaccio, Antonio Monaco, Laura Galiano, et al.
Nature Communications|June 10, 2021
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disordersMaria De Risi, Michele Tufano, Filomena Grazia Alvino, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The EMBO Journal|June 18, 2004
Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitorAnnemieke A Michels, Alessandro Fraldi, Qintong Li, et al.
Annals of the Rheumatic Diseases|November 3, 2012
Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)Tiziana Bachetti, Sabrina Chiesa, Patrizio Castagnola, et al.
Developmental Cell|September 6, 2011
Transcriptional activation of lysosomal exocytosis promotes cellular clearanceDiego L Medina, Alessandro Fraldi, Valentina Bouche, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 19, 2022
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage DiseaseAntonio Monaco, Veronica Maffia, Nicolina Cristina Sorrentino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 23, 2020
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage DiseaseAntonio Monaco, Veronica Maffia, Nicolina Cristina Sorrentino, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIANicolina Cristina Sorrentino, Vincenzo Cacace, Maria De Risi, et al.
Human Gene Therapy|February 15, 2014
Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I/II trialMarc Tardieu, Michel Zérah, Béatrice Husson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 8, 2015
A Comprehensive Map of CNS Transduction by Eight Recombinant Adeno-associated Virus Serotypes Upon Cerebrospinal Fluid Administration in PigsNicolina Cristina Sorrentino, Veronica Maffia, Sandra Strollo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2024
Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIAMarianna Giaccio, Antonio Monaco, Laura Galiano, et al.
Nature Communications|June 10, 2021
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disordersMaria De Risi, Michele Tufano, Filomena Grazia Alvino, et al.
Pageof 5